Icariside I - A novel inhibitor of the kynurenine-AhR pathway with potential for cancer therapy by blocking tumor immune escape

CONCLUSIONS: These results suggest that icariside I could be an effective small molecule drug for tumor immunotherapy by blocking kynurenine-AhR pathway and tumor immune escape.PMID:35834991 | DOI:10.1016/j.biopha.2022.113387

Source: Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie - July 14, 2022 Category: Drugs & Pharmacology Authors: Gui Chen Jiajun Huang Hehua Lei Fang Wu Chuan Chen Yuchen Song Zheng Cao Ce Zhang Cui Zhang Yuxi Ma Mingtao Huang Jinlin Zhou Yujing Lu Yanxia Zhao Limin Zhang Source Type: research